CABLES1

Chr 18

Cdk5 and Abl enzyme substrate 1

Also known as: CABL1, CABLES, HsT2563, IK3-1

The CABLES1 protein regulates cell cycle progression by binding to cyclin-dependent kinases and enhancing their tyrosine phosphorylation, which is critical for neuronal development and outgrowth. Mutations in CABLES1 cause autosomal recessive neurodevelopmental disorders with intellectual disability and developmental delay. This gene is moderately constrained against loss-of-function variants, primarily affecting the nervous system during early development.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
37
P/LP submissions
0%
P/LP missense
0.63
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryCABLES1
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.35) despite low pLI — interpret in context.
📋
ClinVar Variants
35 unique Pathogenic / Likely Pathogenic· 117 VUS of 174 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.63LOEUF
pLI 0.005
Z-score 2.89
OE 0.35 (0.200.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.73Z-score
OE missense 0.70 (0.620.79)
190 obs / 270.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.35 (0.200.63)
00.351.4
Missense OE0.70 (0.620.79)
00.61.4
Synonymous OE0.96
01.21.6
LoF obs/exp: 8 / 22.9Missense obs/exp: 190 / 270.1Syn Z: 0.35
DN
0.6551th %ile
GOF
0.6540th %ile
LOF
0.51top 25%

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

174 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic1
VUS117
Likely Benign6
Conflicting1
34
Pathogenic
1
Likely Pathogenic
117
VUS
6
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
34
0
34
Likely Pathogenic
0
0
1
0
1
VUS
0
109
8
0
117
Likely Benign
0
5
0
1
6
Benign
0
0
0
0
0
Conflicting
1
Total0114431159

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CABLES1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗